cagrilintide and semaglutide 2.4 mg Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Efficacy and safety of co-administered

Speak to a licensed clinician before any health decision.

We're proud to be a trusted partner in the scientific community, supplying high-purity, research-grade peptides for cutting-edge biological research

It has also been used to treat premature ejaculation, chronic depression, pancreatitis, Parkinsons disease, and AIDS myelopathy

Our program combines: Licensed medical provider oversight Structured weight management support Personalized treatment plans Ongoing accountability and education Youre never navigating weight loss alone our care team is with you every step of the way

Only for the growth-hormone-deficiency pattern (poor sleep + low recovery)